日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The inflammatory endotype in osteoarthritis: Reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development

骨关节炎的炎症表型:2024 年 OARSI 临床试验研讨会 (CTS) 的反思,特别关注临床开发的可行性

Karsdal, Morten Asser; Rovati, Lucio C; Tambiah, Jeyanesh; Kubassova, Olga; Ladel, Christoph; Berenbaum, Francis; Bay-Jensen, Anne-Christine; Mclean, Lachy; Loeser, Richard; Mobasheri, Ali; Kraus, Virginia B

Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects

在健康受试者中评估抗CD38细胞溶解抗体TAK-079的安全性、耐受性、药代动力学和药效学

Eric R Fedyk ,Lin Zhao ,Annelize Koch ,Glennda Smithson ,Jose Estevam ,Grace Chen ,Gezim Lahu ,Stefan Roepcke ,Jianchang Lin ,Lachy Mclean

Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study

非布司他治疗高尿酸血症合并高血压患者动态血压的影响:一项 II 期随机安慰剂对照研究

Gunawardhana, Lhanoo; McLean, Lachy; Punzi, Henry A; Hunt, Barbara; Palmer, Robert N; Whelton, Andrew; Feig, Daniel I

Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones

一项随机对照试验比较了非布司他与别嘌醇或安慰剂在尿酸排泄量较高且伴有钙结石患者中的疗效。

Goldfarb, David S; MacDonald, Patricia A; Gunawardhana, Lhanoo; Chefo, Solomon; McLean, Lachy

Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States

原发性干燥综合征:美国患者的健康经历和健康质量预测因素

Segal, Barbara; Bowman, Simon J; Fox, Philip C; Vivino, Frederick B; Murukutla, Nandita; Brodscholl, Jeff; Ogale, Sarika; McLean, Lachy